KEMPHARM INC's ticker is KMPH and the CUSIP is 488445107. A total of 40 filers reported holding KEMPHARM INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $2,600,000 | -15.1% | 399,999 | +3.2% | 0.04% | -23.4% |
| Q1 2018 | $3,063,000 | +73.6% | 387,680 | -11.0% | 0.05% | +80.8% |
| Q4 2017 | $1,764,000 | +9.5% | 435,528 | 0.0% | 0.03% | +13.0% |
| Q3 2017 | $1,611,000 | +5.5% | 435,528 | +14.1% | 0.02% | 0.0% |
| Q2 2017 | $1,527,000 | +71.6% | 381,699 | +110.1% | 0.02% | +53.3% |
| Q1 2017 | $890,000 | +82.8% | 181,699 | +10.1% | 0.02% | +66.7% |
| Q4 2016 | $487,000 | -34.3% | 165,000 | 0.0% | 0.01% | -30.8% |
| Q3 2016 | $741,000 | +12.8% | 165,000 | 0.0% | 0.01% | 0.0% |
| Q2 2016 | $657,000 | -72.5% | 165,000 | 0.0% | 0.01% | -71.7% |
| Q1 2016 | $2,392,000 | -27.0% | 165,000 | 0.0% | 0.05% | -19.3% |
| Q4 2015 | $3,277,000 | +2.5% | 165,000 | 0.0% | 0.06% | +5.6% |
| Q3 2015 | $3,198,000 | – | 165,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Arete Wealth Advisors, LLC | 987,111 | $19,604,000 | 11.88% |
| DSC Advisors, L.P. | 801,257 | $15,913,000 | 8.31% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,420,497 | $28,211,000 | 1.14% |
| Boyle Capital Management, L.L.C. | 34,094 | $677,000 | 0.93% |
| Broadfin Capital, LLC | 732,338 | $14,544,000 | 0.90% |
| Endurant Capital Management LP | 104,886 | $2,083,000 | 0.70% |
| SPHERA FUNDS MANAGEMENT LTD. | 183,954 | $3,653,000 | 0.54% |
| Iowa State Bank | 19,020 | $378,000 | 0.22% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 203,390 | $4,039,000 | 0.20% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 251,689 | $4,999,000 | 0.17% |